Significant Agreements - Additional Information (Details) - USD ($)	1 Months Ended			3 Months Ended		6 Months Ended		12 Months Ended	51 Months Ended
	Jul. 31, 2024	Mar. 31, 2022	Apr. 30, 2021	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2025	Dec. 31, 2024	Jun. 30, 2022
Significant Agreements [Line Items]
Common stock, shares issued				18,702,418		18,702,418		18,702,418	18,702,418	1,356,431
Accrued expenses and other current liabilities				$ 3,971,000		$ 3,971,000		$ 3,971,000	$ 3,971,000	$ 2,195,000
Research and development expenses				8,440,000	$ 3,211,000	14,470,000	$ 5,172,000
University of California, San Diego | License Agreement
Significant Agreements [Line Items]
License agreement payment			$ 200,000
Percentage of common stock issued			5.00%
Potential gross proceeds from sale of equity securities			$ 5,000,000
Common stock, shares issued											137,234
Reimbursement of patent costs incurred			100,000			100,000
License maintenance payments for first four anniversaries			10,000
License maintenance payments for fifth and subsequent anniversary			$ 15,000
Sublicense fee percentage within one year			50.00%
Sublicense fee percentage after first dose			10.00%
Minimum percentage of voting stock			50.00%
Agreement termination written notice period			60 days
Initial cash consideration			$ 200,000
Accrued expenses and other current liabilities										200,000
Research and development expenses			$ 200,000	0	$ 0	100,000	$ 0		100,000
Derivative liability fair value assignment fee				$ 0		$ 0		0	$ 0	0
University of California, San Diego | License Agreement | Common Stock
Significant Agreements [Line Items]
Common stock, shares issued		81,794	55,440
Issuance of shares		$ 200,000	$ 100,000
University of California, San Diego | License Agreement | Minimum
Significant Agreements [Line Items]
One-time cash milestone payment upon event of liquidity			100,000
University of California, San Diego | License Agreement | Maximum
Significant Agreements [Line Items]
One-time cash milestone payment upon event of liquidity			1,000,000
Potential milestone payment upon achievement of development and regulatory milestones			$ 4,600,000
Samsara
Significant Agreements [Line Items]
Accrued expenses and other current liabilities										$ 100,000
Samsara | Royalty Agreement
Significant Agreements [Line Items]
Research and development expenses	$ 32,000,000
Royalty expiration period	10 years
Future royalty payment liability	$ 32,100,000
Percentage of discount rate	25.00%
Interest expense for royalty liability								$ 0
Samsara | Royalty Agreement | Common Stock
Significant Agreements [Line Items]
Redemption of common stock issued	10,080
Repurchase of common shares, value	$ 32,000